This research study aims to understand the functional consequences of paraprotein production in patients with Monoclonal Gammopathy of Unknown Significance (MGUS)
Unravel MGUS started recruiting subjects in August 2016.
Please note that subjects will only be recruited to the trial via their hospital doctor, and it is not possible to volunteer to participate. More than 500 participants have been recruited into the Unravel MGUS study to-date and our nine enrolling centres will continue to recruit until the end of February 2019. Analysis of participant clinical information is at an early stage. Updates can be found on the clinicaltrials.gov website.
The Unravel MGUS team would like to thank all the subjects, and their families, for their support and participation.
Unravel MGUS is sponsored by Human Antibody Factory Limited, a Cambridge based drug discovery company.